Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Defectos moleculares en la diabetes mellitus: terápia génica y celular.

IP: Rafael Simó Canonge
Collaborators: Diego Yeste Fernandez, Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 2769.13
Reference: PI050812
Duration: 01/01/2006 - 31/12/2006

Diabetis, Endocrinologia i Metabolisme

IP: Rafael Simó Canonge
Collaborators: Antonio Luis Andreu Périz, Àlex Fonollosa Calduch, José García Arumí, Francesc Canals Suris, Inés de Torres Ramirez, Cristina Hernández Pascual
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35600
Reference: 2005SGR 00030
Duration: 01/01/2006 - 31/12/2008

Mediadors patogènics de l'edema macular diabètic: estudi comparatiu amb la retinopatia diabètica proliferativa i exploració de nous candidats mitjançant anàlisi proteòmica a l'humor vitri

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Societat Catalana d'Endocrinologia i Nutrició
Funding: 5900
Reference: SCEN/1/2005
Duration: 01/07/2006 - 31/12/2007

Recerca en genètica de malalties neurològiques

IP: Antonio Luis Andreu Périz
Collaborators: Elena García Arumí, Mercè Boada Rovira, Esteve Ribera Pascuet, Rafael Simó Canonge, Josep Gamez Carbonell, Maria Mar Hernandez Guillamon, Ramon Martí Seves
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 36600
Reference: 2005SGR 00971
Duration: 01/01/2006 - 30/05/2010

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
López Gutierrez, Pere

López Gutierrez, Pere

Research technician
Cardiovascular Diseases
Read more
Pascual González, Gabriel

Pascual González, Gabriel

Cardiovascular Diseases
Read more
Falcó Roget, Anna

Falcó Roget, Anna

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.